Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors.
D000818:Animals; D000841:Anisomycin / Q000494:pharmacology*; D001058:Apomorphine / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism*; D003513:Cycloheximide / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology*; D051379:Mice; D011759:Pyrrolidines / Q000494:pharmacology*; D011954:Receptors, Dopamine / Q000378:metabolism*; D013239:Stereotyped Behavior / Q000187:drug effects
D008781:Methyltyrosines; D011759:Pyrrolidines; D011954:Receptors, Dopamine; D000841:Anisomycin; D003513:Cycloheximide; D001058:Apomorphine; D004298:Dopamine; D006719:Homovanillic Acid